Correlation of bivalirudin dose with creatinine clearance during treatment of heparin-induced thrombocytopenia.

Study Objectives: To evaluate steady-state bivalirudin dosing requirements in patients with a wide range of kidney function who were being treated for heparin-induced thrombocytopenia (HIT)-related disorders.

Design: Retrospective medical record review.

Setting: Academic medical center.